Novian Health Secures $11,000,000 Series A Funding Round

  • Feed Type
  • Date
    2/5/2013
  • Company Name
    Novian Health
  • Mailing Address
    430 West Erie Street Chicago, IL 60654
  • Company Description
    Novian Health, located in Chicago and Evry, France, is a privately held company with proprietary technology for the treatment of tumors using Interstitial Laser Therapy (ILT). The company has developed, tested, and patented a minimally-invasive procedure, Novilase, that uses ILT (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional “lumpectomy.”
  • Website
    http://www.novianhealth.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the funding will primarily be used to conduct Novian’s multicenter clinical trials in the U.S., Britain and France on the use of nonsurgical Novilase Interstitial Laser Therapy (ILT) for treating breast cancer.
  • M&A Terms
  • Venture Investor
    iNetworks
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.